Health systems are overwhelmed by rising drug costs, shrinking reimbursement margins, and evolving regulatory expectations.
Payment models are shifting away from fee‑for‑service toward value‑based care.
Payers want outcomes, not just fill rates.
Meanwhile, oversight and policy changes, especially affecting the 340B Drug Pricing Program, require health centers to ensure compliance, transparency, and strategic alignment.
340B has long provided hospitals and clinics with discounted drug pricing and linkages to serve underserved populations. The program now also carries risk: changing legislation, audit scrutiny, and pressure from payers to align with quality metrics. Ignoring these developments threatens both financial stability and patient trust.
But for systems that build a modern pharmacy strategy, 340B becomes more than compliance; it becomes a competitive advantage and a tool for impact.
Key Trends Shaping Tomorrow’s Pharmacy Landscape
AI & Digital Transformation in Pharmacy Practice
Artificial intelligence is not sci‑fi anymore; it’s being embedded into pharmacy workflows. Decision support tools help optimize medication safety, flagged interactions, and dosage adjustments. AI is also optimizing supply chains, predicting inventory demand, and reducing waste.
Digital tools also include electronic prior authorizations, telepharmacy, and ultra-convenient home delivery platforms. These can reduce friction, enhance patient access, and improve health equity.
Value‑Based Care & Outcome‑Driven Payment Models
Health systems are increasingly accountable not just for volume, but for outcome. Models such as alternative payment models (APMs) and shared savings require reporting quality, reducing readmissions, managing chronic disease, and lowering the overall cost of care.
Pharmacies that tie their services (for example, medication therapy management, adherence, transitions of care) to these metrics will find themselves better positioned in contracts.
Patient Centricity: Access, Equity, Continuum of Care
Patients want convenience. They expect pharmacies to be easy to reach, offer home delivery, patient education, and wraparound services. For underserved communities, 340B savings are critical. Ensuring pharmacy access in rural, underserved, or medically disenfranchised areas is more than a mission – it affects health outcomes and institutional reputation.
Reinvestment of 340B savings into patient education, medication access, and community health programs is an increasingly important trend.
Policy Changes, Oversight & 340B Program Reform
Recent calls for increased transparency, clarification of definitions, audit frequency, and oversight mechanisms are affecting how 340B must be managed. Funding, contract pharmacy rules, and risk sharing are areas of ongoing regulatory change.
Staying on top of federal policy, state mandates, and payer‑driven regulations is no longer optional.
Assessing Your Health System’s Readiness
Before moving ahead, health systems must evaluate their current state. Depending on your corporate culture, this can be tricky to do internally. 340B consultants like Remy Healthcare can help. If you choose to go it alone, here are three places to start:
Internal Audit: Ops, Tech, Staffing
Review all pharmacy operations: dispensing, inventory, billing, and compliance.
Evaluate technology stack: are your systems interoperable?
Do you have robust data flows and up‑to‑date EMR/Pharmacy integration?
Analyze staffing: do pharmacists, techs, and administrators have the skills for digital tools, AI, and value metrics?
Understanding Your 340B Program’s Structure & Savings
Map how your 340B program is organized: which entities are covered, whether contract pharmacy models are used, how savings are captured and reinvested. Identify any risk exposure in audits or non‑compliance.
Data Capabilities: Quality, Interoperability & Analytics
The future strategy depends on reliable data. Are you capturing the right metrics (adherence, outcomes, patient satisfaction, cost savings)?
Are your systems capable of giving you real‑time or near-real-time insights?
Can you integrate pharmacy data with clinical, financial, and population health systems? This capability amplifies all other strategy elements.
Step‑by‑Step Strategy Development
With your readiness assessed, it’s time to formalize the strategy. Here’s your playbook:
Vision & Goal Setting: Financial, Clinical, and Patient‑Centric Metrics
Define what success looks like. For example: increase 340B savings by X%, reduce medication non‑adherence by Y%, improve patient satisfaction scores, reduce readmission within 30 days.
Make goals specific, measurable, time‑bound.
Technology Roadmap: Automation, AI, Digital Tools, Integration
Select tech tools that support your vision. AI‑enabled decision support, predictive analytics for inventory, automated workflows for prior authorization and claims, and telepharmacy platforms. Prioritize integration so data flows freely and redundancies are minimized.
Policy & Compliance Plan: 340B Adherence, Regulatory Shifts, Contracts
Update your policies to reflect the latest 340B requirements. Ensure contract pharmacy arrangements, audit readiness, reporting, and documentation are solid. Also anticipate shifts: payer contracts might require outcome metrics, transparency clauses, etc.
Workforce Strategy: Skills, Roles, Governance
You’ll need people who know AI, analytics, clinical pharmacy, and regulatory compliance. Clarify roles and accountability. Create governance structures or committees to oversee strategic implementation and risk. Engage leadership and clinical champion(s) early.
Implementing the Strategy: Tactics That Deliver
Here are practical tactics to bring your winning strategy to life:
- AI‑Powered Clinical Decision Support & Digital Tools in Pharmacy Workflows
Use AI for real‑time alerts on drug interactions, dosing errors, adherence, and to predict patient risk. Leverage digital tools for patients (reminders, teleconsults). This not only improves safety but reduces downstream costs from adverse events and hospitalizations.
- Enhancing 340B Program Value via Maximizing Script Capture, Optimizing Contract Pharmacies
Ensure all eligible outpatient prescriptions are captured. Review contract pharmacy arrangements: ensure they comply, optimize their reach, monitor volume and adherence. Use savings wisely: reinvest into patient support programs, access, and health equity.
- Value‑Based Payment Participation & Alignment with Pharmacy Outcomes
Participate in APMs, shared savings, payer contracts that reward outcomes and care efficiency. Align pharmacy services with value‑based goals: medication adherence, transitions of care, chronic disease management. Document and report outcomes to gain leverage in contract negotiations.
- Patient Access Initiatives: Telepharmacy, Home Delivery, Transition of Care
Extend pharmacy services through telehealth, mail/home delivery, and discharge‑to‑home pharmacy support (e.g. Meds to Beds). These improve experience, reduce readmission, and often align with patient satisfaction metrics that tie into value‑based care.
Monitoring, Adjusting & Scaling
Continuous improvement makes strategy resilient. Here are three pillars for a continuous improvement strategy that ensures gains aren’t just made, but maintained:
Key Performance Indicators: Financial, Clinical, Operational
Track metrics like: 340B savings capture rate; medication adherence; readmission rates; patient satisfaction; AI tool ROI; cost per script; average days to audit resolution; compliance audit pass rates. Use dashboards accessible to leadership and operational teams.
Feedback Loops, Audits & Governance Structure
Set up regular reviews (monthly, quarterly) of performance data. Conduct internal or third‑party audits for 340B, compliance, and outcomes. Governance committees help resolve issues, decide pivots, and mitigate risk.
Scaling Success: Pilot Projects & Phased Rollout
Start with pilots: e.g. test an AI decision support tool in one hospital or service line; try telepharmacy in one region; gradually expand. Use what you learn to refine strategy before scaling system‑wide.
What’s At Stake If You Don’t Adapt. And What You Stand to Gain If You Do.
Not adapting carries risks. Financial leakage, missed savings under 340B, regulatory audit penalties, being outpaced by peers who leverage AI, and losing patient trust. Value‑based contracts will increasingly demand performance and transparency; unprepared systems may face downside risk in reimbursement.
But when health systems act proactively, gains can be substantial. Better margins, improved patient outcomes, stronger community reputation. More efficient operations, less waste, more predictable performance. Patient access improves; satisfaction and equity improve.
Takeaway for leaders: Imagine using the savings from 340B plus efficiency gains from AI to expand services, hire needed staff, implement an infusion lounge, reduce patient out‑of‑pocket costs, and strengthen your position in payor markets. The pharmacy of tomorrow isn’t just a cost center; it’s a strategic asset that delivers.
If you’re ready to build a pharmacy strategy that embraces technology, value‑based care, and patient‑centred outcomes, Remy Healthcare is here to partner in making that future real. Reach out for a consultation, and let’s plan what your future‑ready pharmacy looks like together!